Cipher Pharmaceuticals Inc.
CPHRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $282,166 | $237,996 | $227,695 | $256,459 |
| - Cash | $8,424 | $11,339 | $22,000 | $17,837 |
| + Debt | $13,393 | $25,455 | $40,512 | $40,578 |
| Enterprise Value | $287,135 | $252,112 | $246,207 | $279,200 |
| Revenue | $12,833 | $13,381 | $12,019 | $11,822 |
| % Growth | -4.1% | 11.3% | 1.7% | – |
| Gross Profit | $10,485 | $10,883 | $9,140 | $6,693 |
| % Margin | 81.7% | 81.3% | 76% | 56.6% |
| EBITDA | $6,771 | $6,798 | $4,296 | $1,671 |
| % Margin | 52.8% | 50.8% | 35.7% | 14.1% |
| Net Income | $5,501 | $5,893 | $2,624 | $3,344 |
| % Margin | 42.9% | 44% | 21.8% | 28.3% |
| EPS Diluted | 0.21 | 0.22 | 0.1 | 0.13 |
| % Growth | -4.5% | 120% | -23.1% | – |
| Operating Cash Flow | $10,758 | $6,020 | $4,220 | $8,885 |
| Capital Expenditures | -$81 | $0 | -$2 | -$7 |
| Free Cash Flow | $10,677 | $6,020 | $4,218 | $8,878 |